Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Free Cash Flow (2016 - 2026)

Catalyst Pharmaceuticals filings provide 17 years of Free Cash Flow readings, the most recent being $59.6 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 0.8% to $59.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $208.1 million, a 22.21% decrease, with the full-year FY2025 number at $208.6 million, down 12.81% from a year prior.
  • Free Cash Flow hit $59.6 million in Q1 2026 for Catalyst Pharmaceuticals, up from $44.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $72.6 million in Q3 2024 to a low of $8.5 million in Q1 2022.
  • Median Free Cash Flow over the past 5 years was $44.9 million (2025), compared with a mean of $45.1 million.
  • Biggest five-year swings in Free Cash Flow: soared 192.04% in 2022 and later crashed 55.33% in 2025.
  • Catalyst Pharmaceuticals' Free Cash Flow stood at $40.1 million in 2022, then soared by 38.62% to $55.6 million in 2023, then rose by 27.42% to $70.8 million in 2024, then plummeted by 36.63% to $44.9 million in 2025, then skyrocketed by 32.77% to $59.6 million in 2026.
  • The last three reported values for Free Cash Flow were $59.6 million (Q1 2026), $44.9 million (Q4 2025), and $32.4 million (Q3 2025) per Business Quant data.